Category Archives: Pradaxa

Featured Stories
Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Canadian Research Institutions Named Co-Defendants in Pradaxa Lawsuits in U.S.


In an unusual situation, Canada’s McMaster University and Hamilton Health Sciences have been named co-defendants in lawsuits in U.S. federal court over the safety of the blood-thinning drug Pradaxa (dabigatran). The lawsuits allege that tainted data from mismanaged clinical trials … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

More than 2,000 Lawsuits Over Pradaxa Bleeding Risks, Boehringer Confirms


Boehringer Ingelheim, manufacturer of the blood-thinner Pradaxa (dabigatran), has confirmed that it faces more than 2,000 lawsuits in the United States alleging that the drug causes severe and fatal bleeding. The company’s confirmation came after the German newspaper Handelsblatt reported … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

Pradaxa Maker Sought to Revise, Suppress Controversial, Internal Research


The maker of the controversial blood thinner, Pradaxa, was apparently worried that release of an internal study might impact sales. Boehringer Ingleheim employees allegedly pressured the study’s author to revise or suppress the study, according to recently unsealed legal documents, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Boehringer Fined $931,000 Over Lost Pradaxa Files


Boehringer Ingelheim GmbH, which markets and manufactures Pradaxa, has been charged with a nearly $1 million fine, according to a recent ruling. The fine was levied for the drug maker’s withholding or failing to preserve files sought in Pradaxa litigation, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study Finds Pradaxa Risky for Patients Implanted with Artificial Heart Valves

Pradaxa has been tied to more serious adverse reactions, according to a new study on Behringer Ingelheim’s blood thinner. The research revealed that when Pradaxa (dabigatran) is taken by patients with mechanical heart valves, there is an increase in risks … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study: New Blood Thinners Associated with GI Bleed Risk


Another study revealed issues related to new anti-coagulants, such as Pradaxa, including serious bleeds. The new study revealed that, based on a pooled analysis of 17 randomized controlled trials (RCTs) there was an increased risk of stomach bleeding in patients … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Pradaxa may Increase Viral Infection Risks, Severity, Study Shows

An new study found that the blood thinner, Pradaxa (dabigatran etexilate mesylate), may increase risks viral infections, as well as increasing the severity of these infections. University of North Carolina researchers discovered that the blood thinner blocks a critical component … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA: Blood Thinner, Pradaxa, Should Not Be Used by Patients with Mechanical Prosthetic Heart Valves

Blood thinner, Pradaxa (dabigatran etexilate mesylate), should not be used to prevent stroke or blood clots in patients implanted with mechanical heart valves. The U.S. Food and Drug Administration (FDA) has recently informed health care professionals and the public of … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Was FDA’s Pradaxa® Analysis Flawed?

Despite a growing number of serious gastrointestinal bleed reports linked to Pradaxa®, the U.S. Food & Drug Administration (FDA) argues that the blood thinner, manufactured by Behringer Ingelheim, is safe when used as directed. Pradaxa® was approved two years ago … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA backs previous stance on Pradaxa bleeding risks

Federal health officials have issued an update on its stance on the new blood thinner drug Pradaxa, indicating the risk of severe bleeding associated with the drug is no more significant than any other drugs available on the market for … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.